These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24797065)

  • 1. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy.
    Accogli M; Giani T; Monaco M; Giufrè M; García-Fernández A; Conte V; D'Ancona F; Pantosti A; Rossolini GM; Cerquetti M
    J Antimicrob Chemother; 2014 Aug; 69(8):2293-6. PubMed ID: 24797065
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy.
    Piazza A; Caltagirone M; Bitar I; Nucleo E; Spalla M; Fogato E; D'Angelo R; Pagani L; Migliavacca R
    Adv Exp Med Biol; 2016; 901():77-89. PubMed ID: 26810233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
    Markovska R; Stoeva T; Boyanova L; Stankova P; Pencheva D; Kaneva R; Mitev V; Mitov I
    Infect Dis (Lond); 2017 May; 49(5):429-431. PubMed ID: 28049378
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
    J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
    Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
    Goren MG; Navon-Venezia S; Chmelnitsky I; Carmeli Y
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2687-91. PubMed ID: 20231393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First characterization of fluoroquinolone resistance mechanisms in CTX-M-producing Escherichia coli from Mongolia.
    Kao CY; Udval U; Wu HM; Bolormaa E; Yan JJ; Khosbayar T; Wu JJ
    Infect Genet Evol; 2016 Mar; 38():79-81. PubMed ID: 26692472
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain.
    Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

  • 14. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli.
    Hirakawa H; Nishino K; Yamada J; Hirata T; Yamaguchi A
    J Antimicrob Chemother; 2003 Oct; 52(4):576-82. PubMed ID: 12951338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy.
    Cerquetti M; Giufrè M; García-Fernández A; Accogli M; Fortini D; Luzzi I; Carattoli A
    Clin Microbiol Infect; 2010 Oct; 16(10):1555-8. PubMed ID: 20121822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.
    Oteo J; Cercenado E; Cuevas O; Bautista V; Delgado-Iribarren A; Orden B; Pérez-Vázquez M; García-Cobos S; Campos J
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):270-6. PubMed ID: 20462723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase-producing Enterobacteriaceae during 2011-12 in the Bolzano area (Northern Italy): increasing diversity in a low-endemicity setting.
    Aschbacher R; Giani T; Corda D; Conte V; Arena F; Pasquetto V; Scalzo K; Nicoletti M; Rossolini GM; Pagani E
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):354-6. PubMed ID: 24125922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global incidence of carbapenemase-producing Escherichia coli ST131.
    Peirano G; Bradford PA; Kazmierczak KM; Badal RE; Hackel M; Hoban DJ; Pitout JD
    Emerg Infect Dis; 2014 Nov; 20(11):1928-31. PubMed ID: 25340464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan.
    Yan JJ; Tsai LH; Wu JJ
    Int J Antimicrob Agents; 2012 Sep; 40(3):281-2. PubMed ID: 22789726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.